CONSUN PHARMA (01681) spent about 2.9823 million Hong Kong dollars on repurchasing 200,000 shares on November 5th.
Kangmei Pharmaceutical (01681) announced that it will spend approximately HKD 2.9823 million to repurchase 200,000...
CONSUN PHARMA (01681) announced on November 5, 2025 that they will spend approximately HK$298.23 million to repurchase 200,000 shares.
Related Articles
KING INTL INV (00928) signed a strategic cooperation agreement with Glory Union Group Limited in Hong Kong.
Huatai (06886): In 2025, the company will publicly issue corporate bonds (Series 9) targeting professional investors. The coupon rates for the first and second tranches are 1.85% and 2% respectively.
US Stock Market Move | Jinko Solar (JKS.US) rose over 6%, China's cumulative installed photovoltaic capacity exceeded 1.1 billion kilowatts.
KING INTL INV (00928) signed a strategic cooperation agreement with Glory Union Group Limited in Hong Kong.
Huatai (06886): In 2025, the company will publicly issue corporate bonds (Series 9) targeting professional investors. The coupon rates for the first and second tranches are 1.85% and 2% respectively.
US Stock Market Move | Jinko Solar (JKS.US) rose over 6%, China's cumulative installed photovoltaic capacity exceeded 1.1 billion kilowatts.
RECOMMEND
Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025
Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025
Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025
